About Nimesh Jaiswal
Nimesh Jaiswal's fervent interest in analyzing and interpreting financial data led him to a career as a financial analyst and journalist. The importance of financial statements in driving a stock’s price is the key approach that he follows while advising investors in his articles.
Nimesh majored in accounting and finance in college and is currently pursuing a CMA (Cost & Management Accountant) program.
Recent Articles By Nimesh Jaiswal
Better Buy for 2022: Visa vs. American Express
The credit services industry has made an impressive comeback on rising credit transactions and increased discretionary spending. In addition, the Fed's indication to continue hiking rates until inflation comes under control should bode well for the credit services sector. So, credit services giants Visa (V) and American Express (AXP) should benefit. But which of these stocks is a better buy now? Read more to find out.
Better Buy for 2022: Clover Health vs. Centene
The COVID-19 pandemic has been a blessing for the healthcare plan industry due to increased healthcare spending. In addition, with the rising healthcare needs of an aging population, the industry’s prospects look bright. Clover Health Investments, Corp. (CLOV) and Centene (CNC) should benefit from this trend. But which of these two stocks is a better buy now? Read more to find out.
Down More Than 70% in 2022, Should You Scoop Up Shares of Society Pass?
E-commerce company Society Pass (SOPA) has been making several positive developments, but it is yet to turn profitable. So, let’s find out if it is wise to invest in the company now.
Apple vs. Microsoft: Which Mega-Cap Stock is a Better Buy?
Even though the stock market has been volatile of late on fears related to multi-decade-high inflation and the potential for aggressive central bank interest rate hikes, it could be wise to invest now in quality mega-cap stocks because they are expected to generate steady returns in the long run. We think both Microsoft (MSFT) and Apple (AAPL) should generate stable returns dodging short-term market fluctuations. But which of these two stocks is a better buy now? Read on to learn our view.
Should You Add Smart for Life Stock to Your Portfolio?
Health and wellness products company Smart for Life (SMFL) has made several positive developments. But is it wise to buy the stock now despite ongoing supply-chain disruptions and input price inflation? Read on to learn our view.
Nokia vs. Motorola: Which Stock is a Better Buy?
With the increasing use of various cloud-intensive services and the growing adoption of hybrid working arrangements worldwide, the demand for communication equipment is expected to rise tremendously. So, popular communication equipment stocks Nokia (NOK) and Motorola (MSI) should benefit. But which of these two stocks is a better buy now? Read more to learn our view.
Does Vinco Ventures Deserve a Place in Your Portfolio?
Digital holding company Vinco Ventures (BBIG) reported weak third-quarter financials. And the stock has high short interest. So, can the stock rebound on the company’s leveraging of its broad portfolio of products and services? Read on to learn what we think.
Better Buy for 2022: Advanced Micro Devices vs. Micron Technology
As hybrid working arrangements and digitization are expected to continue and the shift toward electric vehicles (EV) gains momentum, the demand for semiconductor chips is expected to remain high. Therefore, Micron Technology (MU) and Advanced Micro Devices (AMD) should benefit. But which of these stocks is a better buy now? Read more to find out.
Up More Than 15% in 2022, is Howmet Aerospace Still a Buy?
Shares of Howmet Aerospace (HWM) are trading near their 52-week highs and are up more than 15% in 2022. However, can the stock maintain its business momentum amid uncertainty associated with emerging coronavirus cases? Let’s find out.